Literature DB >> 19458555

Visceral pleura invasion impact on non-small cell lung cancer patient survival: its implications for the forthcoming TNM staging based on a large-scale nation-wide database.

Junji Yoshida1, Kanji Nagai, Hisao Asamura, Tomoyuki Goya, Yoshihiko Koshiishi, Yasunori Sohara, Kenji Eguchi, Masaki Mori, Yohichi Nakanishi, Ryosuke Tsuchiya, Etsuo Miyaoka.   

Abstract

INTRODUCTION: No analyses have been reported on the impact of visceral pleura invasion (VPI) on staging, in relation with the International Association for the Study of Lung Cancer proposals for the 7th edition of the tumor, node, metastasis (TNM) classification of the International Union Against Cancer staging system. The purpose of this study was to evaluate the impact of VPI on survival and propose a method of incorporating VPI status into the TNM classification.
METHODS: We reviewed the data on 9758 non-small cell lung cancer patients, who underwent anatomic surgical resection in 1999, accumulated by the Japanese Joint Committee for Lung Cancer Registration, to gain insight into their clinicopathologic characteristics and outcomes. VPI was defined as tumor extension beyond the elastic layer of the visceral pleura. Patients were divided into nine groups according to VPI status and tumor diameter, in accordance with the International Association for the Study of Lung Cancer proposals.
RESULTS: On the basis of survival, the nine groups were divided into the following five levels: tumors < or =2 cm without VPI; tumors < or =2 cm with VPI and tumors 2.1 to 3 cm without VPI; tumors 2.1 to 3 cm with VPI and tumors 3.1 to 5 cm without VPI; tumors 3.1 to 5 cm with VPI and tumors 5.1 to 7 cm without VPI; and tumors 5.1 to 7 cm with VPI and tumors >7 cm without VPI or T3 tumors.
CONCLUSIONS: The T status of tumors, 7 cm or less, with VPI should be upgraded to the next T level in the future edition of the TNM classification of International Union Against Cancer staging system.

Entities:  

Mesh:

Year:  2009        PMID: 19458555     DOI: 10.1097/JTO.0b013e3181a85d5e

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  25 in total

1.  Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller.

Authors:  Jun-ichi Nitadori; Adam J Bograd; Kyuichi Kadota; Camelia S Sima; Nabil P Rizk; Eduardo A Morales; Valerie W Rusch; William D Travis; Prasad S Adusumilli
Journal:  J Natl Cancer Inst       Date:  2013-08-07       Impact factor: 13.506

2.  Visceral pleural invasion does not affect recurrence or overall survival among patients with lung adenocarcinoma ≤ 2 cm: a proposal to reclassify T1 lung adenocarcinoma.

Authors:  Jun-Ichi Nitadori; Christos Colovos; Kyuichi Kadota; Camelia S Sima; Inderpal S Sarkaria; Nabil P Rizk; Valerie W Rusch; William D Travis; Prasad S Adusumilli
Journal:  Chest       Date:  2013-11       Impact factor: 9.410

3.  Visceral pleural invasion in lung adenocarcinoma ≤3 cm with ground-glass opacity: a clinical, pathological and radiological study.

Authors:  Li-Lan Zhao; Hui-Kang Xie; Li-Ping Zhang; Jun-Yan Zha; Fang-Yu Zhou; Ge-Ning Jiang; Chang Chen
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

4.  Peripheral lung adenocarcinomas harboring epithelial growth factor receptor mutations with microRNA-135b overexpression are more likely to invade visceral pleura.

Authors:  Hanbo Le; Xiaoling Wang; Yao Zha; Jie Wang; Wangyu Zhu; Zhinan Ye; Xiaoguang Liu; Haijie Ma; Yongkui Zhang
Journal:  Oncol Lett       Date:  2017-10-16       Impact factor: 2.967

5.  Clinicopathological features of small-sized peripheral squamous cell lung cancer.

Authors:  Takayuki Kosaka; Kimihiro Shimizu; Seshiru Nakazawa; Misaki Iijima; Yoichi Ohtaki; Yoko Azuma; Kai Obayashi; Toshiteru Nagashima; Toshiki Yajima; Akira Mogi; Hiroyuki Kuwano; Ken Shirabe
Journal:  Mol Clin Oncol       Date:  2019-11-18

6.  Visceral Pleural Invasion in Pulmonary Adenocarcinoma: Differences in CT Patterns between Solid and Subsolid Cancers.

Authors:  Benedikt H Heidinger; Ursula Schwarz-Nemec; Kevin R Anderson; Constance de Margerie-Mellon; Antonio C Monteiro Filho; Yigu Chen; Marius E Mayerhoefer; Paul A VanderLaan; Alexander A Bankier
Journal:  Radiol Cardiothorac Imaging       Date:  2019-08-29

7.  Re-evaluation of the prognostic value of visceral pleura invasion in Stage IB non-small cell lung cancer using the prospective multicenter ACOSOG Z0030 trial data set.

Authors:  Juan J Fibla; Stephen D Cassivi; Alessandro Brunelli; Paul A Decker; Mark S Allen; Gail E Darling; Rodney J Landreneau; Joe B Putnam
Journal:  Lung Cancer       Date:  2012-10-03       Impact factor: 5.705

8.  Visceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size.

Authors:  Elizabeth David; Peter F Thall; Neda Kalhor; Wayne L Hofstetter; David C Rice; Jack A Roth; Stephen G Swisher; Garrett L Walsh; Ara A Vaporciyan; Caimea Wei; Reza J Mehran
Journal:  Ann Thorac Surg       Date:  2013-05-02       Impact factor: 4.330

Review 9.  Integrated imaging of non-small cell lung cancer recurrence: CT and PET-CT findings, possible pitfalls and risk of recurrence criteria.

Authors:  Andrea Caulo; Saeed Mirsadraee; Fabio Maggi; Lucia Leccisotti; Edwin J R van Beek; Lorenzo Bonomo
Journal:  Eur Radiol       Date:  2011-10-04       Impact factor: 5.315

10.  Visceral pleural invasion in T1 tumors (≤3 cm), particularly T1a, in the eighth tumor-node-metastasis classification system for non-small cell lung cancer: a population-based study.

Authors:  Tao Zhang; Jia-Tao Zhang; Wen-Feng Li; Jun-Tao Lin; Si-Yang Liu; Hong-Hong Yan; Jin-Ji Yang; Xue-Ning Yang; Yi-Long Wu; Qiang Nie; Wen-Zhao Zhong
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.